TickerFactsScreenerDevelopers

Actinium Pharmaceuticals, Inc. (ATNM) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2000: $1.11M2001: -$1.73M2002: -$1.68M2003: $1.57M2004: $439.1K2005: $74.3K2006: $1.82M2007: $3.46M2008: $4.16M2009: $845.2K2010: $399.1K2011: $992.0K2012: $1.15M2013: -$1.56M2014: -$1.92M2015: $21.97M2016: $18.01M2017: $13.67M2018: $8.81M2019: $5.64M2020: $61.32M2021: $73.55M2022: $66.48M2023: $36.38M2024: $32.76M2025: $7.83M$7.83M
2000Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$7.83M-76.1%
2024$32.76M-10.0%
2023$36.38M-45.3%
2022$66.48M-9.6%
2021$73.55M+19.9%
2020$61.32M+986.4%
2019$5.64M-36.0%
2018$8.81M-35.5%
2017$13.67M-24.1%
2016$18.01M-18.0%
2015$21.97M+1243.0%
2014-$1.92M-23.3%
2013-$1.56M-236.1%
2012$1.15M+15.5%
2011$992.0K+148.6%
2010$399.1K-52.8%
2009$845.2K-79.7%
2008$4.16M+20.2%
2007$3.46M+89.7%
2006$1.82M+2355.4%
2005$74.3K-83.1%
2004$439.1K-72.1%
2003$1.57M+193.9%
2002-$1.68M+3.3%
2001-$1.73M-256.4%
2000$1.11M—